Ultragenyx Pharmaceutical (RARE) Q2 2016 Earnings

9MayConfirmed
Q3 2015
Q4 2015
Q1 2016
Q2 2016
-1.42
-1.16
-0.9
-0.64

Details

Expected EPS
-1.31
Actual EPS
-1.35
Surprise EPS
-0.04
Surprise Percent
+3.05%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -1.35 per share for Q2 2016.

0 Comments

Share your thoughts